# Dexmedetomidine and Propofol for Sedation in Cataract Surgery.

> **NCT07556133** · NA · RECRUITING · sponsor: **Saint-Joseph University** · enrollment: 1000 (estimated)

## Conditions studied

- Sedation
- Cataract
- Hemodynamic
- Hemodynamic Changes
- Dexmedetomidine
- Propofol Dosage
- Fentanyl
- Bradycardia
- Tachycardia
- Nausea and Vomiting

## Interventions

- **DRUG:** Dexmedetomidine (DEX)
- **DRUG:** Propofol (PRO)
- **DRUG:** Fentanyl (FEN)

## Key facts

- **NCT ID:** NCT07556133
- **Lead sponsor:** Saint-Joseph University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-09
- **Primary completion:** 2026-11-09
- **Final completion:** 2026-12-09
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07556133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07556133, "Dexmedetomidine and Propofol for Sedation in Cataract Surgery.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07556133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*